Kamil Faridi, MD, MSc
Assistant ProfessorDownloadHi-Res Photo
Cards
Appointments
Cardiovascular Medicine
Primary
Contact Info
About
Titles
Assistant Professor
Biography
Kamil Faridi is an Assistant Professor of Medicine in the Section of Cardiovascular Medicine at the Yale School of Medicine and an Investigator at the Yale Center for Outcomes Research and Evaluation. He received his medical degree from the Duke University School of Medicine and went on to complete his residency training in Internal Medicine at The Johns Hopkins Hospital and fellowship in Cardiovascular Medicine at Beth Israel Deaconess Medical Center. As a cardiology fellow, he also completed a research fellowship at the BIDMC Smith Center for Outcomes Research in Cardiology and received a Master of Science Degree in Epidemiology at the Harvard T.H. Chan School of Public Health. He is board certified in internal medicine, cardiovascular medicine, and echocardiography, and is a general cardiologist and echocardiographer at Yale New Haven Hospital. He is a member of the American College of Cardiology, the American Heart Association, and the American Society of Echocardiography.
Dr. Faridi’s research interests include primary and secondary prevention of atherosclerotic cardiovascular disease and stroke, utilization of cardiovascular medications and echocardiography in clinical practice, and effective use of real-world evidence to enhance cardiovascular care. He has recently been awarded the Yale Center for Clinical Investigation (YCCI) Junior Faculty Scholar Award to pursue outcomes research in cardiology.
Appointments
Cardiovascular Medicine
Assistant ProfessorPrimary
Other Departments & Organizations
Education & Training
- MSc
- Harvard T.H. Chan School of Public Health, Epidemiology (2020)
- Research Fellow
- Smith Center for Outcomes Research in Cardiology
- Cardiology Fellowship
- Beth Israel Deaconess Medical Center (2019)
- Residency
- Johns Hopkins Hospital (2016)
- MD
- Duke University School of Medicine (2013)
- BS
- Duke University (2008)
Research
Research at a Glance
Yale Co-Authors
Frequent collaborators of Kamil Faridi's published research.
Publications Timeline
A big-picture view of Kamil Faridi's research output by year.
Jeptha Curtis, MD
David J. Hur, MD, FACC, FASE, FSCCT, FSCMR
James V. Freeman, MD, MPH, MS
Nihar Desai, MD, MPH
Ralph J. Riello III, PharmD, BCPS
Robert McNamara, MD, MHS, FAHA, FACC, FASE
69Publications
1,025Citations
Publications
2024
Association of Physician Certification and Outcomes Among Patients Undergoing Left Atrial Appendage Occlusion.
Vora AN, Pereira LA, Du C, Tan Z, Huang CY, Friedman DJ, Wang Y, Faridi KF, Lakkireddy DR, Zimmerman S, Higgins AY, Kapadia SR, Curtis JP, Freeman JV. Association of Physician Certification and Outcomes Among Patients Undergoing Left Atrial Appendage Occlusion. JACC Cardiovasc Interv 2024 PMID: 39474982, DOI: 10.1016/j.jcin.2024.10.020.Peer-Reviewed Original ResearchRethinking Our Roots: The Ground-Up Approach to Heart Health & Planetary Sustainability
Saad A, Brandt E, Faridi K, Paster J, Sheth S, Freeman A, Ramirez V, Aggarwal M. Rethinking Our Roots: The Ground-Up Approach to Heart Health & Planetary Sustainability. The American Journal Of Medicine 2024 PMID: 39383927, DOI: 10.1016/j.amjmed.2024.09.028.Peer-Reviewed Original ResearchConceptsPlanetary healthCardiovascular diseasePromote planetary healthPoor dietary habitsModifiable risk factorsNutrition educationChronic illnessDietary habitsFood insecurityRisk factorsHealthPlant-forward dietsTreat cardiovascular diseasesUnited StatesFood systemsAgricultural practicesDiseasePracticeComplex issuesIllnessNutritionHabitsEducationProposed Mechanisms and Associations of COVID-19 with Cardiometabolic Risk Factors
Reddy K, Faridi K, Aggarwal M, Tirumalai A, Singh T, Tejtel K, Williams K, Litwin S, Dastmalchi L, White B, Barnard N, Ornish D, Batts T, Ajene G, Aspry K, Kris Etherton P, Hull S, Freeman A. Proposed Mechanisms and Associations of COVID-19 with Cardiometabolic Risk Factors. American Journal Of Lifestyle Medicine 2024 DOI: 10.1177/15598276241269532.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsCardiometabolic riskLifestyle choicesCardiovascular diseaseHealthy lifestyle choicesCardiometabolic risk factorsHealth promotionReduce disease burdenCode BlueCardiovascular healthDisease preventionCOVID-19 morbidityPoor nutritionDisease burdenCOVID-19Disease burden resultsPublic healthGlobal leading causeLeading causeRisk factorsAssociation of COVID-19HealthLifestyleBurden resultsNutritionCardiovascular medicineContemporary Patterns of Medicare and Medicaid Utilization and Associated Spending on Tafamidis in Cardiac Amyloidosis
Bansal K, Majmundar V, Young G, Riello R, Faridi K, Ahmad T, Desai N. Contemporary Patterns of Medicare and Medicaid Utilization and Associated Spending on Tafamidis in Cardiac Amyloidosis. JACC Heart Failure 2024, 12: 1791-1793. PMID: 39115517, DOI: 10.1016/j.jchf.2024.07.002.Peer-Reviewed Original ResearchProcedure Volume and Outcomes With WATCHMAN Left Atrial Appendage Occlusion
Friedman D, Du C, Zimmerman S, Tan Z, Lin Z, Vemulapalli S, Kosinski A, Piccini J, Pereira L, Minges K, Faridi K, Masoudi F, Curtis J, Freeman J. Procedure Volume and Outcomes With WATCHMAN Left Atrial Appendage Occlusion. Circulation Cardiovascular Interventions 2024, 17: e013466. PMID: 38889251, PMCID: PMC11189610, DOI: 10.1161/circinterventions.123.013466.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsVolume-outcome relationshipLikelihood of procedural successLeft atrial appendage occlusionProcedural successProcedure volumeAppendage occlusionNational Cardiovascular Data Registry LAAO RegistryVolume quartilesLeft atrial appendage occlusion devicesThree-level hierarchical generalized linear modelsMinimum volume thresholdsWatchman FLX deviceProcedural success rateHierarchical generalized linear modelsAssociated with outcomePhysician volumeWATCHMAN procedureFLX deviceOcclusion deviceVolume thresholdCardiovascular proceduresPhysiciansHospitalNational analysisSuccess rateSerum Lipoproteins Are Associated With Coronary Atherosclerosis in Asymptomatic U.S. Adults Without Traditional Risk Factors
Faridi K, Lahan S, Budoff M, Cury R, Feldman T, Pan A, Fialkow J, Nasir K. Serum Lipoproteins Are Associated With Coronary Atherosclerosis in Asymptomatic U.S. Adults Without Traditional Risk Factors. JACC Advances 2024, 3: 101049. PMID: 39129991, PMCID: PMC11312344, DOI: 10.1016/j.jacadv.2024.101049.Peer-Reviewed Original ResearchAltmetricConceptsTraditional risk factorsNon-HDL-CLDL-CRisk factorsAssociated with atherosclerosisCoronary atherosclerosisLipoprotein cholesterolAtherosclerotic cardiovascular disease riskSerum non-HDL-COptimal risk factorsLow-risk adultsActive tobacco useCardiovascular disease riskAssociation of low-density lipoprotein cholesterolAsymptomatic middle-aged adultsNon-high-density lipoprotein cholesterolAtherosclerosis prevalenceCoronary computed tomography angiographyHigh-risk plaque featuresMiddle-aged adultsAtherogenic lipoproteinsHigh LDL-CLow-density lipoprotein cholesterolLevels of atherogenic lipoproteinsMultivariate logistic regressionHigh- versus low-gradient aortic stenosis: Is our evaluation limited by aorto-mitral angle on cardiovascular CT?
See C, Kim Y, Park J, Wang Y, Reinhardt S, Shkolnik E, Faridi K, Lombo B, Bellumkonda L, McNamara R, Sugeng L, Hur D. High- versus low-gradient aortic stenosis: Is our evaluation limited by aorto-mitral angle on cardiovascular CT? International Journal Of Cardiology 2024, 409: 132174. PMID: 38754590, DOI: 10.1016/j.ijcard.2024.132174.Peer-Reviewed Original ResearchConceptsNormal-flow low-gradientAortic valve areaTranscatheter AV replacementParadoxical low-flow low-gradientCardiovascular CTTransthoracic echocardiogramCalcium scoreAS patientsDiagnosis of severe ASLow-gradient aortic stenosisHG-AS patientsLG-AS patientsLow-flow low-gradientAorto-mitral angleAortic valve (AV) stenosisLG-ASPLFLG-ASAV replacementSevere ASConsecutive patientsAortic stenosisValve areaAS phenotypeClinical managementEchocardiogramUtilization of Fixed-Dose Combination Treatment for Hypertension in Medicare and Medicaid From 2016 to 2020
Essa M, Ross J, Dhruva S, Desai N, Spatz E, Faridi K. Utilization of Fixed-Dose Combination Treatment for Hypertension in Medicare and Medicaid From 2016 to 2020. Circulation Cardiovascular Quality And Outcomes 2024, 17: e010697. PMID: 38712553, DOI: 10.1161/circoutcomes.123.010697.Peer-Reviewed Original ResearchCitationsAltmetricMedicare Coverage and Patient Out-of-Pocket Costs for Cardiovascular-Kidney-Metabolic Medications
Young G, Bansal K, Riello R, Clark K, Dhruva S, Faridi K, Desai N. Medicare Coverage and Patient Out-of-Pocket Costs for Cardiovascular-Kidney-Metabolic Medications. JAMA Network Open 2024, 7: e2412437. PMID: 38771578, PMCID: PMC11109768, DOI: 10.1001/jamanetworkopen.2024.12437.Peer-Reviewed Original ResearchAltmetricPragmatic Trial of Messaging to Providers About Treatment of Hyperlipidemia (PROMPT-LIPID): A Randomized Clinical Trial
Shah N, Ghazi L, Yamamoto Y, Kumar S, Martin M, Simonov M, Riello Iii R, Faridi K, Ahmad T, Wilson F, Desai N. Pragmatic Trial of Messaging to Providers About Treatment of Hyperlipidemia (PROMPT-LIPID): A Randomized Clinical Trial. Circulation Cardiovascular Quality And Outcomes 2024, 17: e010335. PMID: 38634282, DOI: 10.1161/circoutcomes.123.010335.Peer-Reviewed Original ResearchCitationsAltmetricConceptsElectronic health recordsElectronic health record alertsHigh-risk atherosclerotic cardiovascular diseaseLipid lowering therapyAtherosclerotic cardiovascular diseasePragmatic trialCardiovascular diseaseProportion of patientsYale New Haven HealthLDL-CSecondary outcomesPrimary outcomeInternal medicine cliniciansEHR alertUsual careHealth recordsProvider levelCluster-randomizedLDL-C managementLDL-C levelsAdverse cardiovascular eventsRandomized clinical trialsTreatment of hyperlipidemiaCliniciansCardiovascular events
Clinical Trials
Current Trials
Multimodal Outcome CHAracterization (MOCHA) in comatose cardiac arrest patients
HIC ID1506016080REGRoleSub InvestigatorPrimary Completion Date12/31/2025Recruiting ParticipantsGenderBothAge18+ years
Academic Achievements & Community Involvement
honor K23 Career Development Award
National AwardNIH/NHLBIDetails09/20/2022United Stateshonor Yale Center for Clinical Investigation Scholar Award
Yale University AwardYale UniversityDetails08/01/2020United States
Clinical Care
Overview
Kamil Faridi, MD, provides care for patients with complex cardiovascular medical conditions. He specializes in diagnosing and treating various arrhythmias.
Dr. Faridi's research interests include aortic stenosis detection and management, trends in cardiovascular medication use, and atrial fibrillation-related mortality. He also examines the challenges in evaluating specific heart valve issues and the impact of imaging techniques on procedures that prevent blood clots in the heart.
A Yale Center for Clinical Investigation (YCCI) Scholar and recipient of the K23 Career Development Award, Dr. Faridi's research has received support from the National Heart, Lung, and Blood Institute.
Dr. Faridi is an assistant professor at Yale University School of Medicine
Clinical Specialties
Cardiovascular Medicine
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileNews
News
- November 05, 2024
Yale Researchers at American Heart Association Scientific Session 2024
- April 01, 2024
Yale Faculty Present Groundbreaking Clinical Research at the 2024 American College of Cardiology Scientific Sessions
- August 23, 2023
Artificial Intelligence Automates Diagnosis of Severe Heart Valve Disease
- August 07, 2023
Greater Use of Combination Therapy Would Reduce Heart Attacks and Strokes in Patients with Atherosclerotic Cardiovascular Disease, Yale Cardiologists Say